Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
|
KR |
|
Bain Capital Specialty Finance Inc
NYSE:BCSF
|
US |
Intrinsic Value
The intrinsic value of Dongkook Pharmaceutical Co Ltd (086450) under the Base Case is 21 775.26 KRW per share. Compared with the current market price of 24 050 KRW, the stock appears Overvalued by 9% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Dongkook Pharmaceutical Does
Dongkook Pharmaceutical is a South Korean drug maker that develops, manufactures, and sells medicines for everyday medical needs. Its lineup includes prescription drugs and branded over-the-counter products such as pain relief patches, digestive remedies, and cold or cough medicines. In simple terms, it turns pharmaceutical ingredients into finished medicines that patients can buy through doctors, hospitals, clinics, pharmacies, and drug wholesalers.
- Headquarters
- Korea KR
- Employees
- 1 233
- IPO date
- May 29, 2007
Revenue & Expenses Breakdown
Dongkook Pharmaceutical Co Ltd
Earnings Waterfall
Dongkook Pharmaceutical Co Ltd
The intrinsic value for Dongkook Pharmaceutical Co Ltd (086450) under the Base Case is 21 775.26 KRW.
Compared with the current market price of 24 050 KRW, the stock appears Overvalued by 9% .